Linlin Zhang,1,2,* Arun K lyer,3,4,* Xiaoqian Yang,1 Eisuke Kobayashi,1 Yuqi Guo,1,2 Henry Mankin,1 Francis J Hornicek,1 Mansoor M Amiji,3 Zhenfeng Duan1 1Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA; 2Department of Pathology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China; 3Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, Massachusetts, USA; 4Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA *These authors contributed equally to this work Abstract: Our prior sc...
Breast cancer is a very heterogenous disease that affects millions each year. Although it is the mos...
Although bone has an intrinsic capacity for self repair, the healing of large bone defects that typi...
The current study shows the therapeutic outcome achieved in triple negative breast cancer (TNBC) by ...
Our prior screening of microRNAs (miRs) identified that miR-199a-3p expression is reduced in osteosa...
Our prior screening of microRNAs (miRs) identified that miR-199a-3p expression is reduced in osteosa...
Patients diagnosed with osteosarcoma undergo extensive surgical intervention and chemotherapy result...
The presence of dormant, microscopic cancerous lesions poses a major obstacle for the treatment of m...
BackgroundThe use of neo-adjuvant chemotherapy in treating osteosarcoma has improved patients' avera...
RNA interference (RNAi) is a process in which small non-coding, double-stranded RNA (dsRNA) regulate...
Mingxiang Cai,1,* Li Yang,2,* Shufan Zhang,1 Jiafan Liu,2 Yao Sun,1 Xiaogang Wang2 1Engineering Rese...
The use of neo-adjuvant chemotherapy in treating osteosarcoma has improved patients' average 5 year ...
Fen Wang,1,* Jia-Dong Pang,2,* Lei-lei Huang,1 Ran Wang,1 Dan Li,3 Kang Sun,4 Lian-tang Wang,1,* Li-...
Recent years have witnessed growing attention toward synthesising polymeric nanoparticles for pharma...
Targeted delivery of RNA-based therapeutics for cancer therapy remains a challenge. We have develope...
Objectives: The tumor suppressor p53 plays a crucial role in the development of osteosarcoma. The pr...
Breast cancer is a very heterogenous disease that affects millions each year. Although it is the mos...
Although bone has an intrinsic capacity for self repair, the healing of large bone defects that typi...
The current study shows the therapeutic outcome achieved in triple negative breast cancer (TNBC) by ...
Our prior screening of microRNAs (miRs) identified that miR-199a-3p expression is reduced in osteosa...
Our prior screening of microRNAs (miRs) identified that miR-199a-3p expression is reduced in osteosa...
Patients diagnosed with osteosarcoma undergo extensive surgical intervention and chemotherapy result...
The presence of dormant, microscopic cancerous lesions poses a major obstacle for the treatment of m...
BackgroundThe use of neo-adjuvant chemotherapy in treating osteosarcoma has improved patients' avera...
RNA interference (RNAi) is a process in which small non-coding, double-stranded RNA (dsRNA) regulate...
Mingxiang Cai,1,* Li Yang,2,* Shufan Zhang,1 Jiafan Liu,2 Yao Sun,1 Xiaogang Wang2 1Engineering Rese...
The use of neo-adjuvant chemotherapy in treating osteosarcoma has improved patients' average 5 year ...
Fen Wang,1,* Jia-Dong Pang,2,* Lei-lei Huang,1 Ran Wang,1 Dan Li,3 Kang Sun,4 Lian-tang Wang,1,* Li-...
Recent years have witnessed growing attention toward synthesising polymeric nanoparticles for pharma...
Targeted delivery of RNA-based therapeutics for cancer therapy remains a challenge. We have develope...
Objectives: The tumor suppressor p53 plays a crucial role in the development of osteosarcoma. The pr...
Breast cancer is a very heterogenous disease that affects millions each year. Although it is the mos...
Although bone has an intrinsic capacity for self repair, the healing of large bone defects that typi...
The current study shows the therapeutic outcome achieved in triple negative breast cancer (TNBC) by ...